Search research articles
Contact Us
Filters
Showing results (41-50 of 128) with videos related to
Page
of 13
Sort By:
Dalton Transactions (Cambridge, England : 2003)
|
August 9, 2008
Structure and dynamics of methyl cis-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside complexes with PtCl(2) and PdCl(2), by (1)H, (2)H, (13)C, (15)N and (195)Pt NMR spectroscopy in DMSO, CD(3)CN and H(2)O
Elzbieta Bednarek, Jerzy Sitkowski, Robert Kawecki, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2023
Anthracycline-induced cardiotoxicity - are we about to clear this hurdle?
Wolfram C M Dempke, Rafal Zielinski, Christina Winkler, et al.
Chembiochem : a European Journal of Chemical Biology
|
March 23, 2023
Development of a Novel Tool To Demystify Drug Distribution at Tissue-Blood Barriers
Elizabeth A Hughes, Rafał Zieliński, Ashley E Ray, et al.
Oncology Research
|
November 24, 2004
The ability of new sugar-modified derivatives of antitumor anthracycline, daunorubicin, to stimulate NAD(P)H oxidation in different cellular oxidoreductase systems: NADH dehydrogenase, NADPH cytochrome P450 reductase, and xanthine oxidase
Jolanta Pawłowska, Waldemar Priebe, Mark J I Paine, et al.
Oncology Research
|
November 3, 2005
A bisanthracycline (WP631) represses uPAR gene expression and cell migration of RKO colon cancer cells by interfering with transcription factor binding to a chromatin-accessible -148/-124 promoter region
Rajesh R Nair, Heng Wang, M S Jamaluddin, et al.
BMC Cancer
|
September 30, 2025
Shared and non-overlapping functions of RECQL4 and BLM helicases in chemotherapeutics-induced glioma cell responses
Kamil Wojnicki, Bartosz Wojtas, Iwona A Ciechomska, et al.
Molecular Cancer Therapeutics
|
July 8, 2010
Degrasyn potentiates the antitumor effects of bortezomib in mantle cell lymphoma cells in vitro and in vivo: therapeutic implications
Lan V Pham, Archito T Tamayo, Changping Li, et al.
RSC Advances
|
April 4, 2025
Crystal structure and polymorphic forms of auranofin revisited
Marcin Ziemniak, Damian Trzybiński, Sylwia Pawlędzio, et al.
ACS Pharmacology & Translational Science
|
April 17, 2025
Chemistry Outside the Flask: Redefining Selectivity In Vivo with Image Guidance
Erik Cressman, Danielle Stolley, Natalie Fowlkes, et al.
Cancer Translational Medicine
|
August 22, 2017
Novel Molecular Multilevel Targeted Antitumor Agents
Poonam Sonawane, Young A Choi, Hetal Pandya, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 128) with videos related to
Sort By:
Page
of 13
Dalton Transactions (Cambridge, England : 2003)
|
August 9, 2008
Structure and dynamics of methyl cis-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside complexes with PtCl(2) and PdCl(2), by (1)H, (2)H, (13)C, (15)N and (195)Pt NMR spectroscopy in DMSO, CD(3)CN and H(2)O
Elzbieta Bednarek, Jerzy Sitkowski, Robert Kawecki, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2023
Anthracycline-induced cardiotoxicity - are we about to clear this hurdle?
Wolfram C M Dempke, Rafal Zielinski, Christina Winkler, et al.
Chembiochem : a European Journal of Chemical Biology
|
March 23, 2023
Development of a Novel Tool To Demystify Drug Distribution at Tissue-Blood Barriers
Elizabeth A Hughes, Rafał Zieliński, Ashley E Ray, et al.
Oncology Research
|
November 24, 2004
The ability of new sugar-modified derivatives of antitumor anthracycline, daunorubicin, to stimulate NAD(P)H oxidation in different cellular oxidoreductase systems: NADH dehydrogenase, NADPH cytochrome P450 reductase, and xanthine oxidase
Jolanta Pawłowska, Waldemar Priebe, Mark J I Paine, et al.
Oncology Research
|
November 3, 2005
A bisanthracycline (WP631) represses uPAR gene expression and cell migration of RKO colon cancer cells by interfering with transcription factor binding to a chromatin-accessible -148/-124 promoter region
Rajesh R Nair, Heng Wang, M S Jamaluddin, et al.
BMC Cancer
|
September 30, 2025
Shared and non-overlapping functions of RECQL4 and BLM helicases in chemotherapeutics-induced glioma cell responses
Kamil Wojnicki, Bartosz Wojtas, Iwona A Ciechomska, et al.
Molecular Cancer Therapeutics
|
July 8, 2010
Degrasyn potentiates the antitumor effects of bortezomib in mantle cell lymphoma cells in vitro and in vivo: therapeutic implications
Lan V Pham, Archito T Tamayo, Changping Li, et al.
RSC Advances
|
April 4, 2025
Crystal structure and polymorphic forms of auranofin revisited
Marcin Ziemniak, Damian Trzybiński, Sylwia Pawlędzio, et al.
ACS Pharmacology & Translational Science
|
April 17, 2025
Chemistry Outside the Flask: Redefining Selectivity In Vivo with Image Guidance
Erik Cressman, Danielle Stolley, Natalie Fowlkes, et al.
Cancer Translational Medicine
|
August 22, 2017
Novel Molecular Multilevel Targeted Antitumor Agents
Poonam Sonawane, Young A Choi, Hetal Pandya, et al.
Page
of 13